Radiotherapy, Adjuvant
9
4
6
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer
Safety and Efficacy of IMPT or IMRT for Breast Cancer
Effects of Radiotherapy in Borderline and Malignant Phyllodes Tumors After R0 Resection
Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer
Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer
Dosimetric Comparison of Target Volume, Heart and Left Lung in Post Mastectomy Radiotherapy (RT) of Left Sided Breast Cancer by Free Breathing (FB) Versus Deep Inspiration Breath Hold (DIBH) Technique
Shared Decision Making With Breast Cancer Patients